Marksans operates with a strategic and distinctive model to achieve its vision of establishing a globally respected, profitable, and integrated pharmaceutical company. Our focus extends to generic pharmaceutical formulation research, manufacturing, and marketing, supported by four state-of-the-art facilities located in India, the United Kingdom, and the United States. Through an unwavering commitment to Quality Control (QC) and Quality Assurance (QA), we have successfully carved out a distinctive niche within the pharmaceutical ecosystem where we operate.
Accreditations
Quality is at the core of our operations, and we are fully compliant with benchmark industry standards and regulations such as
- US Food and Drug Administration (US FDA)
- Therapeutic Goods Administration (TGA), Australia
- Medicines and Healthcare products Regulatory Agency (MHRA), UK
- EU Health Authority
- Health Canada
- Japanese Health Authority in Accreditations
Our Product Portfolio
Tablets (plain, enteric-coated and film-coated)
Hard capsules
Soft gelatin capsules
Oral liquids
Ointments